CORD-19:00adbbcc70c39794b7d91a479943c84cc33db30a / 33188-33489 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T216","span":{"begin":0,"end":301},"obj":"Sentence"}],"text":"In a field trial using IBR MLV vaccine at arrival, the incidence of upper respiratory disease was reduced from 17.2% in 3371 unvaccinated calves to 1 % in 3345 vaccinates (RR = 16; P\u003cO.OOOO),us A well-designed trial using IBR MLV vaccine given on arrival failed to show benefits in health performance."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T216","span":{"begin":0,"end":301},"obj":"Sentence"},{"id":"T10790","span":{"begin":0,"end":301},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In a field trial using IBR MLV vaccine at arrival, the incidence of upper respiratory disease was reduced from 17.2% in 3371 unvaccinated calves to 1 % in 3345 vaccinates (RR = 16; P\u003cO.OOOO),us A well-designed trial using IBR MLV vaccine given on arrival failed to show benefits in health performance."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T125","span":{"begin":23,"end":26},"obj":"Disease"},{"id":"T126","span":{"begin":74,"end":93},"obj":"Disease"},{"id":"T127","span":{"begin":94,"end":97},"obj":"Disease"},{"id":"T128","span":{"begin":222,"end":225},"obj":"Disease"}],"attributes":[{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0025089"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0005087"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0025089"}],"text":"In a field trial using IBR MLV vaccine at arrival, the incidence of upper respiratory disease was reduced from 17.2% in 3371 unvaccinated calves to 1 % in 3345 vaccinates (RR = 16; P\u003cO.OOOO),us A well-designed trial using IBR MLV vaccine given on arrival failed to show benefits in health performance."}